Contact lens and atropine for slowing myopia in children
Part of Eyes & vision clinical trials.
This study tests whether combining a special contact lens with atropine eye drops can slow down the progression of nearsightedness (myopia) in children. It aims to find a more effective way to prevent their vision from getting worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 7 and 12 years old.
- Your nearsightedness must be within a certain range (moderate, not too mild or too severe).
- You must not have used any previous treatments to slow down myopia progression.
- You must have healthy eyes with no current eye infections or need for eye medications.
- You must be able to wear contact lenses and not have allergies to atropine or other eye drops used in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether atropine eye drops can reduce the progression of myopia (nearsightedness, where you have trouble seeing far away) in children. It might help slow down the worsening of vision over time.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
This study tests whether special glasses (called H.O.P.E. lenses) combined with a low-dose atropine eye drop can slow down the progression of myopia (nearsightedness) in children. It aims to help keep your child's vision from getting worse as they grow.
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.